小细胞肺癌的药物治疗研究进展(5)
[8] Rhee CK， Lee SH， Kim JS， et al. A multicenter phase II study of belotecan， a new camptothecin analogue， as a secondline therapy in patients with small cell lung cancer [J]. Lung Cancer， 2011， 72(1)： 64-67.[9] Jeong J， Cho BC， Sohn JH， et al. Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy： a phase II trial [J]. Lung Cancer ......
您现在查看是摘要页，全文长 2708 字符。